Patients are categorized into aggressive and potentially lethal disease based on tumor (T) stage, Gleason grade, the number of cores with tumor in the diagnostic biopsy, prostate-specific antigen (PSA), and imaging [3]. Here, KLK3 is linked to neoplasm.